U.S. states began using the Pfizer-BioNTech vaccine to inoculate younger adolescents against COVID-19 after advisers to the CDC backed the plan in a unanimous vote.
The U.S. Food and Drug Administration authorized the vaccine for children aged 12 to 15
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2025. All rights reserved.